Search Results - Yong‐Chen Lu

Refine Results
  1. 1
    Cancer immunotherapy targeting neoantigens

    Cancer immunotherapy targeting neoantigens by Yong‐Chen Lu, Paul F. Robbins

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Targeting neoantigens for cancer immunotherapy: Table 1.

    Targeting neoantigens for cancer immunotherapy: Table 1. by Yong‐Chen Lu, Paul F. Robbins

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy

    Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy by Yong‐Chen Lu, Lee Jia, Zhili Zheng, Eric Tran, Paul F. Robbins, Steven A. Rosenberg

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing

    Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing by Yong‐Chen Lu, Zhili Zheng, Frank J. Lowery, Jared J. Gartner, Todd D. Prickett, Paul F. Robbins, Steven A. Rosenberg

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Differential Role for c-Rel and C/EBPβ/δ in TLR-Mediated Induction of Proinflammatory Cytokines

    Differential Role for c-Rel and C/EBPβ/δ in TLR-Mediated Induction of Proinflammatory Cytokines by Yong‐Chen Lu, Ira Kim, Elizabeth Lye, Fang Shen, Nobutaka Suzuki, Shinobu Suzuki, Steve Gerondakis, Shizuo Akira, Sarah L. Gaffen, Wen-Chen Yeh, Pamela S. Ohashi

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer

    Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer by Xin Yao, Mojgan Ahmadzadeh, Yong‐Chen Lu, David J. Liewehr, Mark E. Dudley, Fang Liu, David S. Schrump, Seth M. Steinberg, Steven A. Rosenberg, Paul F. Robbins

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer by Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

    T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer by Eric Tran, Paul F. Robbins, Yong‐Chen Lu, Todd D. Prickett, Jared J. Gartner, Lee Jia, Anna Pasetto, Zhili Zheng, Satyajit Ray, Eric Groh, Isaac Kriley, Steven A. Rosenberg

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors

    An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors by Yong‐Chen Lu, Zhili Zheng, Paul F. Robbins, Eric Tran, Todd D. Prickett, Jared J. Gartner, Yong F. Li, Satyajit Ray, Zulmarie Franco, Valery Bliskovsky, Peter Fitzgerald, Steven A. Rosenberg

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

    Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions by Yong‐Chen Lu, Xin Yao, Jessica S. Crystal, Yong F. Li, Mona El‐Gamil, Colin Gross, Lindy Davis, Mark E. Dudley, James C. Yang, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression

    Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression by Yong‐Chen Lu, Xin Yao, Yong F. Li, Mona El‐Gamil, Mark E. Dudley, James C. Yang, Jorge R. Almeida, Daniel C. Douek, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

    Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells by Paul F. Robbins, Yong‐Chen Lu, Mona El‐Gamil, Yong F. Li, Colin Gross, Jared J. Gartner, Jimmy Lin, Jamie K. Teer, Paul F. Cliften, Eric Tycksen, Yardena Samuels, Steven A. Rosenberg

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Immunogenicity of somatic mutations in human gastrointestinal cancers

    Immunogenicity of somatic mutations in human gastrointestinal cancers by Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, Alena Gros, Simon Turcotte, Paul F. Robbins, Jared J. Gartner, Zhili Zheng, Yong F. Li, Satyajit Ray, John R. Wunderlich, Robert Somerville, Steven A. Rosenberg

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer by Eric Tran, Simon Turcotte, Alena Gros, Paul F. Robbins, Yong‐Chen Lu, Mark E. Dudley, John R. Wunderlich, Robert Somerville, Katherine Hogan, Christian S. Hinrichs, Maria R. Parkhurst, James C. Yang, Steven A. Rosenberg

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

    Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients by Gal Cafri, Rami Yossef, Anna Pasetto, Drew C. Deniger, Yong‐Chen Lu, Maria R. Parkhurst, Jared J. Gartner, Lee Jia, Satyajit Ray, Lien T. Ngo, Mohammad Jafferji, Abraham Sachs, Todd D. Prickett, Paul F. Robbins, Steven A. Rosenberg

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

    Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer by Winifred Lo, Maria R. Parkhurst, Paul F. Robbins, Eric Tran, Yong‐Chen Lu, Lee Jia, Jared J. Gartner, Anna Pasetto, Drew C. Deniger, Parisa Malekzadeh, Thomas E. Shelton, Todd D. Prickett, Satyajit Ray, Scott Kivitz, Biman C. Paria, Isaac Kriley, David S. Schrump, Steven A. Rosenberg

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

    Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma by Stephanie L. Goff, Richard A. Morgan, James C. Yang, Richard M. Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily Lu, Zhili Zheng, Liqiang Xi, Monica Epstein, Lori McIntyre, Parisa Malekzadeh, Mark Raffeld, Howard A. Fine, Steven A. Rosenberg

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

    Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3 by Yong‐Chen Lu, Linda L. Parker, Tangying Lu, Zhili Zheng, Mary Ann Toomey, Donald E. White, Xin Yao, Yong F. Li, Paul F. Robbins, Steven A. Feldman, Pierre van der Bruggen, Christopher A. Klebanoff, Stephanie L. Goff, Richard M. Sherry, Udai S. Kammula, James C. Yang, Steven A. Rosenberg

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

    Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer by Nikolaos Zacharakis, Harshini Chinnasamy, Mary A. Black, Hui Xu, Yong‐Chen Lu, Zhili Zheng, Anna Pasetto, Michelle M. Langhan, Thomas E. Shelton, Todd D. Prickett, Jared J. Gartner, Lee Jia, Katarzyna Trebska-McGowan, Robert Somerville, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or<i>Candida</i>

    A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or<i>Candida</i> by Mayumi Nakagawa, Teresa Evans, Milan Bimali, Hannah Coleman, Jasmine Crane, Nadia Darwish, Jennifer L. Faulkner, Amy H. Jones, Haley Kelly, Benjamin J. Lieblong, Yong‐Chen Lu, Keanna Marsh, Intawat Nookaew, Charles M. Quick, David W. Ussery, Michael S. Robeson, Sumit K. Shah, Takeo Shibata, H. Williams, William W. Greenfield

    Published 2025
    Get full text
    Pré-impressão
    Save to List
    Saved in:

Search Tools: